Form 8-K - Current report:
SEC Accession No. 0000950123-09-018028
Filing Date
2009-06-26
Accepted
2009-06-26 16:53:17
Documents
3
Period of Report
2009-06-26
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K c87391e8vk.htm 8-K 8812
2 EXHIBIT 99.1 c87391exv99w1.htm EX-99.1 9826
3 GRAPHIC c87391p87391_01.gif GRAPHIC 3872
  Complete submission text file 0000950123-09-018028.txt   25717
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 033-80623 | Film No.: 09913597
SIC: 2835 In Vitro & In Vivo Diagnostic Substances